Profile of specific antibodies to SARS-CoV-2: The first report

被引：155

作者：

Xiao, Ai Tang ^{[1
]}

Gao, Chun ^{[2
]}

Zhang, Sheng ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Jie Fang Ave 1095, Wuhan, Peoples R China

[2] Huazhong Univ Sci & Technol, Dept Gastrointestinal Surg, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China

来源：

JOURNAL OF INFECTION | 2020年 / 81卷 / 01期

关键词：

CORONAVIRUS;

D O I：

10.1016/j.jinf.2020.03.012

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：174 / 175

页数：2

共 7 条

[1]

China National Health, 2020, CHINA NATL HLTH COMM

[2] Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance [J].

Mo, HY ;

Zeng, GQ ;

Ren, XL ;

Li, H ;

Ke, CW ;

Tan, YX ;

Cai, CD ;

Lai, KF ;

Chen, RC ;

Chan-Yeung, MR ;

Zhong, NS .

RESPIROLOGY, 2006, 11 (01) :49-53

[3] Viral load of SARS-CoV-2 in clinical samples [J].

Pan, Yang ;

Zhang, Daitao ;

Yang, Peng ;

Poon, Leo L. M. ;

Wang, Quanyi .

LANCET INFECTIOUS DISEASES, 2020, 20 (04) :411-412

[4] Emergence of a novel coronavirus causing respiratory illness from Wuhan, China [J].

Tang, Julian W. ;

Tambyah, Paul A. ;

Hui, David S. C. .

JOURNAL OF INFECTION, 2020, 80 (03) :350-352

[5]

World Health Organization, 2004, SUMM PROB SARS CAS O

[6] Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [J].

Wu, Zunyou ;

McGoogan, Jennifer M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (13) :1239-1242

[7]

Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI [10.1056/NEJMc2001737, 10.1148/radiol.2020200463]

← 1 →